The New York Times shared breaking news from federal health agencies early Tuesday morning (Apr. 13) recommending that the United States put a temporary halt on administering the Johnson & Johnson COVID-19 vaccine following reports that six individuals developed a rare disorder involving blood clots within two weeks of vaccination. CNN reports that a joint statement from Dr. Peter Marks — director of the Food and Drug Administration’s Center for Biologics Evaluation and Research — and Dr. Anne Schuchat — principal deputy director of the Centers for Disease Control and Prevention (CDC) — was released stating, the following: “[The] CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. [The] FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of...